1 |
Mahoney LB, Rosen R. The spectrum of reflux phenotypes[J]. Gastroenterol Hepatol (NY), 2019, 15(12): 646-654.
|
2 |
Liang S, Wu X, Jin F. Gut-brain psychology: rethinking psychology from the microbiota–gut–brain axis[J]. Front Integr Neurosci, 2018, 12: 33.
|
3 |
杨艳, 张艇, 张芳旭, 等.莫沙必利片联合奥美拉唑镁肠溶片治疗质子泵抑制药-难治性胃食管反流病患者的临床研究[J]. 中国临床药理学杂志, 2021, 37(21): 2875-2877.
|
4 |
Broers C, Geeraerts A, Boecxstaens V, et al. The role of serotonin in the control of esophageal sensitivity assessed by multimodal stimulation in health[J]. Neurogastroenterol Motil, 2021, 33(3): e14057.
|
5 |
买买提·依斯热依力, 吾布力卡斯木·吾拉木, 艾克拜尔·艾力,等. 慢性束缚应激对小鼠胃食管的影响[J/OL]. 中华胃食管反流病电子杂志, 2018, 5(2): 14-18.
|
6 |
买买提·依斯热依力, 艾克拜尔·艾力, 买买提艾力·艾则孜, 等.心理应激对小鼠脂肪组织黄嘌呤氧化酶表达、活性及相关指标的影响[J]. 中国应用生理学杂志, 2019, 35(6): 494-499.
|
7 |
Liang S, Wu X, Hu X, et al. recognizing depression from the microbiota–gut–brain axis[J]. Int J Mol Sci, 2018, 19(6): 1592.
|
8 |
Liu MY, Zhang LJ, Zhou YX, et al. 5-hydroxytryptamine changes under different pretreatments on rat models of myocardial infarction and/or depression[J]. Chin Med J (Engl), 2017, 130(18): 2219-2225.
|
9 |
Carhart-Harris RL, Nutt DJ. Serotonin and brain function: a tale of two receptors[J]. J Psychopharmacol, 2017, 31(9): 1091-1120.
|
10 |
Fuertig R, Azzinnari D, Bergamini G, et al. Mouse chronicsocial stress increases blood and brain kynurenine pathway activity and fearbehaviour:Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase[J]. Brain Behav Immun, 2016, 54: 59-72.
|
11 |
Kiyozumi Y, Baba Y, Okadome K, et al. Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer[J]. Cancer Sci, 2019, 110(6): 1863-1871.
|
12 |
Distrutti E, Monaldi L, Ricci P, et al. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies[J]. World J Gastro enterol, 2016, 22(7): 2219-2241.
|
13 |
Mbongue JC, Nicholas DA, Torrez TW, et al. The role of indoleamine 2, 3-dioxygenase in immune suppression and autoimmunity[J]. Vaccines (Basel), 2015, 3(3): 703-729.
|
14 |
Hillman L, Yadlapati R, Thuluvath AJ, et al. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease[J]. Dis Esophagus, 2017, 30(9): 1-15.
|
15 |
韩士举, 林强, 韩伟, 等.选择性5-羟色胺再摄取抑制剂在胃食管反流病治疗中的应用现状[J]. 实用医学杂志, 2021, 37(22): 2946-2949.
|
16 |
姜志茹, 赵雷, 郭海, 等.5-羟色胺在非糜烂性反流病中表达的研究[J]. 胃肠病学和肝病学杂志, 2017, 26(11): 1282-1284.
|
17 |
艾合麦提·喀斯木, 买买提·依斯热依力, 克力木·阿布都热依木.肠道菌群在胃食管反流病发病中的作用及相关性研究进展[J]. 中国医师杂志, 24(8): 1273-1276.
|
18 |
Chow CFW, Che S, Qin HY, et al. From psychology to physicality: how nerve growth factor transduces early life stress into gastrointestinal motility disorders later in life[J]. Cell Cycle, 2019, 18(16): 1824-1829.
|